Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-09-06
1998-08-25
Lankford, Jr., Leon B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 424 941, 424 945, 530380, 530381, 530384, A61K 3816, A61K 3836, A61K 3843
Patent
active
057983321
ABSTRACT:
Reagents that specifically bind a carbohydrate target wherein sialic acid is linked at the nonreducing terminus of a glycoside to a galactose or galactosamine residue through an .alpha.2-6 linkage are able to inhibit the conversion of human Factor X to human Factor Xa. These reagents (SA/Gal/GalNAc binding reagents) as well as other strategies for inhibiting the conversion of Factor X to Factor Xa are useful in treating thrombosis, inflammation and other conditions associated with excess thrombin activity.
REFERENCES:
patent: 4668621 (1987-05-01), Doellgast et al.
patent: 4742046 (1988-05-01), Bliah
patent: 5059654 (1991-10-01), Hou et al.
patent: 5190919 (1993-03-01), Fair et al.
patent: 5453272 (1995-09-01), Heerze et al.
Sata, T.; et al., American Journal of Pathology, vol. 139(6), Dec. 1991, pp. 1435-1448.
Chattopadhay, A; et al., The Journal of Biological Chemistry, vol. 264(19), Jul. 5, 1989, pp. 11035-11043.
Jesty, J; et al., The Journal of Biological Chemistry, vol. 250(12), Jun. 25 1975, pp. 4497-4504.
Freussinet, J., FEBS Letters, vol. 124(1), Feb. 1981, pp. 48-52.
Yin, E.T. et al., J. of Biological Chemistry, vol. 246(11), pp. 3694-3702, Jun. 1971.
Hortin, G.L. et al., Analytical Biochemistry, vol. 188(2), pp. 271-277, 1990.
Engel, A.M. Thromb. Haemostasis, vol. 46(1), p. 297, abstract #0934, 1981.
Seegers, W.H. et al., Thrombosis Research, vol. 1(5), pp. 443-460, 1972.
Louis D. Herze et al.; "Comparison of the Lectin-Like Activity of Pertussis Toxin with Two Plant Lectins That Have Differential Specificities for .alpha.(2-6) and .alpha.(2-3)-Linked Sialic Acid" Biochemical and Biophysical Research Communication; vol. 172, No. 3; Nov. 15, 1990; pp. 1224-1229.
Duffy et al., J. Biol. Chem., vol. 267, pp. 7821-7827 (1992) Apr. (issue #11).
Inoue et al., Eur. J. Biochem., vol. 218, pp. 153-163 (1993).
Nakagawa et al., Glycoconjugate Journal, vol. 12, pp. 173-181 (1995).
Okamoto et al., J. Inher. Metab. Dis., vol. 16, pp. 435-440 (1993).
Hoover et al., Cell (1978) 14:423-428.
Etingin et al., Cell (1990) 61:657-662.
Davie, E.W., Haemostasis and Thrombosis, Second Edition, R.W. Coleman et al., eds., (1987) J.B. Lippencott, Philadelphia, PA, Chapter 6, pp. 242-267.
Furie et al., Cell (1988) 53:505-518.
Steinberg et al., Haemostasis and Trombosis, Second Edition, R.W. Colman et al., eds., (1987) J.B. Lippencott, Philadelphia, PA, Chapter 7 pp. 112-119.
Di Scipio et al., Biochemistry (1977) 16:5253-5260.
Watzke et al., J. Biol. Chem. (1990) 285:11982-11989.
Nesheim et al., J. Biol. Chem. (1979) 254:10952:10962.
Nesheim et al., J. Biol. Chem (1981) 256(13):6537-6540.
Skogen et al., J. Biol. Chem. (1984) 259(4):2306-2310.
Krishnaswamy et al., J. Biol. Chem. (1988) 263(8):3823-3824.
Husten et al., J. Biol. Chem. (1987) 262(27):12953-12961.
Girard et al., Nature (1989) 338:518-520.
Girard et al., Science (1990) 248:1421-1424.
Dunwiddie et al., J. Biol. Chem. (1989) 264:16694-16699.
Waxman et al., Science (1990) 248:593-596.
Titani, Proc. Natl. Acad. Sci. (1975) 72:3082-3086.
Fair et al., J. Clin. Invest. (1979) 648:884-894.
Mizouchi et al., J. Biol. Chem. (1980) 255:3526-3531.
Hase et al., J. Biol. Chem. (1990) 265:1858-1861.
Sinha Uma
Wolf David L.
COR Therapeutics Inc.
Lankford , Jr. Leon B.
Prats Francisco C.
LandOfFree
Glycosylation-mediated inhibition of factor X does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycosylation-mediated inhibition of factor X, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycosylation-mediated inhibition of factor X will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36333